My call is flat to up, this will take time, be greatful for the opportunity to top up, just my thoughts:)
I don't think the board below are wasting time and letting opportunity be overtaken by defeat, yes time is needed but opportunity is knocking around the world at that same time!!
The board comprises five highly qualified members with relevant experience in medical diagnostics. The OvPlex UK Scientific Advisory Board comprises:
Dr Amrit Takhar, GP Principal at Wansford and Kings Cliffe Practice, member of Northamptonshire Local Medical Committee and the Strategic Management Group of the East Midlands (EMSY) Primary Care Research Network
Dr Malcolm Padwick, Clinical lead for gynaecological cancer and colposcopy for West Hertfordshire, highly experienced and regarded cancer surgeon
Dr Fergus Macpherson, National Head of Pathology with Spire Healthcare Limited, former Deputy Hospital Director at Spire Murrayfield Hospital in Edinburgh, Scotland
Ms Louise Bayne, CEO of ovarian cancer support charity Ovacome, member of National Cancer Research Network
Prof Sean Kehoe, President of British Gynaecological Cancer Society and medical advisor to Ovacome
The endeavour by Intus to establish this impressive board shows how seriously it is treating the UK launch and longevity of OvPlex, says Nick Gatsios, managing director of HealthLinx. We could not have asked for more of Intus at this stage of the rollout.
HTX Price at posting:
14.0¢ Sentiment: LT Buy Disclosure: Held